54
Growth Score
pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
586155
Nanopharmaceutics discover and develop targeted therapeutic products for the treatment of cancer, CNS disorders, and infectious diseases.
About the Company
Nanopharmaceutics, Inc. is a clinical-stage specialty pharmaceutical company that is developing oral, topical, and injectable products for cancer, central nervous system (CNS) disorders, and infectious diseases. Nanopharmaceutics is focused on formulation development aimed at improving drug absorption and stability by leveraging its expertise in
nanoparticle and fine-particle formulations, which can specifically be used to improve difficult-to-deliver BCS category II and IV drugs.
